Synthesis and biological evaluation of new steroidal pyridines as potential anti-prostate cancer agents

Synthesis and biological evaluation of new steroidal pyridines as potential anti-prostate cancer... A series of new steroidal pyridines have been synthesized through the based-promoted three-component reaction and preliminarily evaluated for their antiproliferative activity against different types of cancer cell lines. SARs studies showed that the heterocyclic rings attached to the 4-position of the pyridine ring were preferred over the phenyl rings for the activity. Among these compounds, the most potent compound exhibited good growth inhibition against all the tested cancer cells, especially for PC-3 cells with an IC50 value of 1.55 μM. Further mechanistic studies revealed that the most potent compound inhibited colony formation, migration and evasion of PC-3 cells in a concentration-dependent manner as well as induced apoptosis of PC-3 cells possibly through the mitochondria-related apoptotic pathways. Caspase-3/-9 and PARP were activated, finally leading to the apoptosis of PC-3 cells. For the androgen-sensitive (AR+) prostate cancer cell line LNCaP, the most potent compound was less potent than abiraterone with the IC50 value of 8.48 and 3.29 μM, respectively. The most potent compound could be used as a starting point for the development of new steroidal heterocycles with improved anticancer potency and selectivity. The synthesized steroidal pyridines contain the functional -OEt and CN groups, which could be used for further modifications for the construction of the steroid library. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Journal of Medicinal Chemistry Elsevier

Synthesis and biological evaluation of new steroidal pyridines as potential anti-prostate cancer agents

Synthesis and biological evaluation of new steroidal pyridines as potential anti-prostate cancer agents

European Journal of Medicinal Chemistry 145 (2018) 11e22 Contents lists available at ScienceDirect European Journal of Medicinal Chemistry journal homepage: http://www.elsevier.com/locate/ejmech Research paper Synthesis and biological evaluation of new steroidal pyridines as potential anti-prostate cancer agents a, b, c, d, 1 a, b, c, d, 1 a, b, c, d a, b, c, d Yun-Kai Shi , Bo Wang , Xiao-Li Shi , Yuan-Di Zhao , a, b, c, d, * a, b, c, d, ** Bin Yu , Hong-Min Liu Key Laboratory of Advanced Drug Preparation Technologies (Zhengzhou University), Ministry of Education, PR China Collaborative Innovation Center of New Drug Research and Safety Evaluation, Henan Province, PR China School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, PR China Key Laboratory of Henan Province for Drug Quality and Evaluation, PR China art i cle i nfo abstract Article history: A series of new steroidal pyridines have been synthesized through the based-promoted three-compo- Received 23 October 2017 nent reaction and preliminarily evaluated for their antiproliferative activity against different types of Received in revised form cancer cell lines. SARs studies showed that the heterocyclic rings attached to the 4-position of the 29 December 2017 pyridine ring were preferred over the phenyl rings for the activity. Among these compounds, the most Accepted 30 December 2017 potent compound exhibited good growth inhibition against all the tested cancer cells, especially for PC- Available online 2 January 2018 3 cells with an IC value of 1.55 mM. Further mechanistic studies revealed that the most potent com- pound inhibited colony formation, migration and evasion of PC-3 cells in a concentration-dependent Keywords: manner as well as induced apoptosis of PC-3 cells possibly through the mitochondria-related apoptotic Steroids pathways. Caspase-3/-9 and PARP were activated, finally leading to the apoptosis of PC-3 cells. For the Pyridines androgen-sensitive (AR ) prostate cancer...
Loading next page...
 
/lp/elsevier/synthesis-and-biological-evaluation-of-new-steroidal-pyridines-as-4Z4eeHBroH
Publisher
Elsevier
Copyright
Copyright © 2018 Elsevier Masson SAS
ISSN
0223-5234
eISSN
1768-3254
D.O.I.
10.1016/j.ejmech.2017.12.094
Publisher site
See Article on Publisher Site

Abstract

A series of new steroidal pyridines have been synthesized through the based-promoted three-component reaction and preliminarily evaluated for their antiproliferative activity against different types of cancer cell lines. SARs studies showed that the heterocyclic rings attached to the 4-position of the pyridine ring were preferred over the phenyl rings for the activity. Among these compounds, the most potent compound exhibited good growth inhibition against all the tested cancer cells, especially for PC-3 cells with an IC50 value of 1.55 μM. Further mechanistic studies revealed that the most potent compound inhibited colony formation, migration and evasion of PC-3 cells in a concentration-dependent manner as well as induced apoptosis of PC-3 cells possibly through the mitochondria-related apoptotic pathways. Caspase-3/-9 and PARP were activated, finally leading to the apoptosis of PC-3 cells. For the androgen-sensitive (AR+) prostate cancer cell line LNCaP, the most potent compound was less potent than abiraterone with the IC50 value of 8.48 and 3.29 μM, respectively. The most potent compound could be used as a starting point for the development of new steroidal heterocycles with improved anticancer potency and selectivity. The synthesized steroidal pyridines contain the functional -OEt and CN groups, which could be used for further modifications for the construction of the steroid library.

Journal

European Journal of Medicinal ChemistryElsevier

Published: Feb 10, 2018

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off